TEVA
$22.09
Revenue | $4332Mn |
Net Profits | $-437Mn |
Net Profit Margins | -10.09% |
Teva Pharmaceutical Industries Ltd’s revenue jumped 12.52% since last year same period to $4332Mn in the Q3 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 4.08% jump in its revenue since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit fell -646.25% since last year same period to $-437Mn in the Q3 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 48.28% jump in its net profits since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit margin fell -585.47% since last year same period to -10.09% in the Q3 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 50.31% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.65 |
EPS Estimate Current Year | 0.65 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.65 - a 18.18% jump from last quarter’s estimates.
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.65.
Earning Per Share (EPS) | 0.69 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) jumped 15% since last year same period to 0.69 in the Q3 2024. This indicates that the Teva Pharmaceutical Industries Ltd has generated 15% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-08 | 0.51 | 0.48 | -5.88% |
2024-07-31 | 0.55 | 0.61 | 10.91% |
2024-11-06 | 0.65 | 0.69 | 6.15% |